Immunic, Inc. (IMUX) Q3 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Immunic, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.009 -- 00:00:04.171 Good morning and welcome to Munich's third quarter 2023 earnings call. 00:00:04.171 -- 00:00:08.253 My name is Jessica Bru, head of investor relations and communications at the Munich. 00:00:08.253 -- 00:00:10.934 I will also be the moderator on today's call. 00:00:10.934 -- 00:00:15.557 Speaking on the call are Dr. Daniel Fitt, our chief executive officer and president, 00:00:15.557 -- 00:00:18.678 as well as Glenn Whaley, our chief financial officer. 00:00:18.678 -- 00:00:22.482 Please note that all participants will be in this nonly mode and this event is being 00:00:22.482 -- 00:00:27.706 recorded. After today's presentation, there will be an opportunity to ask questions. 00:00:27.706 -- 00:00:32.291 If you join the webcast via the Zoom platform, there are two ways to submit questions. 00:00:32.291 -- 00:00:36.795 You can either submit your questions in writing via the Q&A tool of the Zoom portal, 00:00:36.795 -- 00:00:40.838 or if you would like to speak with us directly, please use the raise hand function in 00:00:40.838 -- 00:00:44.008 the Zoom portal to queue your question. 00:00:44.008 -- 00:00:48.853 Before we begin, I would like to remind you that this presentation may contain forward-looking 00:00:48.853 -- 00:00:54.580 statements. Such statements can be identified by words such as may, will, expect, anticipate, 00:00:54.580 -- 00:00:59.345 estimate, or words with a similar meaning, and such statements involve a number of risks 00:00:59.345 -- 00:01:03.649 and uncertainties that could cause Immunex's actual results to differ materially from 00:01:03.649 -- 00:01:08.134 those discussed here. Please note that these forward-looking statements reflect Immunix's 00:01:08.134 -- 00:01:12.839 opinions only as of the date of th...